Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Janone Inc - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH
Ticker
Exchange
SIC #
Website
Latest Ticker
JAN
Nasdaq
8731
https://janone.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Janone Inc
JanOne Regains Compliance with Nasdaq's Listing Requirements
- Mar 15th, 2024 1:00 pm
JanOne to Present at the Dawson James 8th Annual Investment Conference
- Sep 21st, 2023 3:30 pm
Dawson James Securities Announces October Date for 8th Annual Small Cap Growth Conference
- Sep 21st, 2023 1:35 pm
JanOne to Present In Person and by Video at H.C. Wainwright's 25th Annual Global Investment Conference
- Aug 31st, 2023 5:30 pm
JanOne Earns US Patent for the Use of its Novel Formulation of Low-Dose Naltrexone, Jan123, to Treat Chronic Pain
- Aug 29th, 2023 5:30 pm
JanOne Wins "Best Abstract" Award at the Ohio Society of Interventional Pain Physicians Annual Meeting
- Aug 25th, 2023 6:30 pm
JanOne Technologies Announces Closing of Registered Direct Offering Priced At-The-Market under Nasdaq Rules
- Aug 22nd, 2023 9:30 pm
JanOne Technologies Announces Registered Direct Offering Priced At-The-Market under Nasdaq Rules
- Aug 18th, 2023 11:00 pm
JanOne to Present Prior Phase II Data on Diabetic Neuropathy at the Ohio Society of Interventional Pain Physicians Annual Meeting
- Aug 18th, 2023 4:42 pm
JanOne files international patent application for methods of using low dose naltrexone to treat chronic pain
- Jun 28th, 2023 12:30 pm
JanOne Completes Pre-IND Meeting with FDA on Jan123
- Apr 18th, 2023 12:30 pm
JanOne to Present Data On Its Two Non-Opioid Drug Candidates at The Appalachian Region Spine and Pain Meeting on Drug Development Programs to Treat Pain on April 15, 2023
- Apr 13th, 2023 12:30 pm
Scroll